Technologies Available for Licensing
For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil
METHOD FOR TREATING, PREVENTING, OR INHIBITING ENTEROTOXIGENIC ESCHERICHIA COLI INFECTIONS WITH BOVINE RED BLOOD CELLS
Compounds of Formulas Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. ##STR1##
Number:2005-0158284
Application:11/007,695
Date:2005-07-21
Type: Pending
Category: Treatment
More Detail:Visit USPTO.GOV
For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil